Actavis Launches Generic Pulmicort Respules
Pulmicort Respules are indicated as maintenance treatment to control and prevent asthma symptoms in patients aged 12 months to 8 years. Budesonide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity. Corticosteroids have been shown to have a wide range of inhibitory activities against multiple cell types (eg, mast cells, eosinophils, neutrophils, macrophages, lymphyocytes), and mediators (eg, histamine, eicosanoids, leukotrienes, and cytokines) involved in allergic- and non-allergic-mediated inflammation.
Budesonide Inhalation Suspension is available in 0.25mg and 0.5mg vials.,p>For more information call (800) 432-8534 or visit Actavis.com.